LAG3 and cancer: Lymphocyte activation gene-3 (LAG-3) is an immune checkpoint receptor that delivers an inhibitory signal to activated T cells upon major histocompatibility complex (MHC) class II binding, and which is upregulated on infiltrating T cells in many cancer types (1, 2).